The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Author [ Title(Asc)] Type Year
Filters: Author is Polyzos, Stergios A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2012).  Sulfated oxysterols as candidates for the treatment of nonalcoholic fatty liver disease.. Metabolism. 61(6), 755-8.
Anastasilakis, A. D., Polyzos S. A., & Nikolopoulos P. (2008).  Subendothelial carotid hematoma after fine-needle aspiration biopsy of a solitary thyroid nodule.. J Ultrasound Med. 27(10), 1517-20.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2011).  Spironolactone revisited.. J Clin Hypertens (Greenwich). 13(10), 783-4.
Makri, E. S., Goulas A., & Polyzos S. A. (2021).  Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease.. Eur J Pharmacol. 907, 174272.
Kouvari, M., Polyzos S. A., Chrysohoou C., Skoumas J., Pitsavos C. S., Panagiotakos D. B., et al. (2022).  Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.. Clin Nutr. 41(6), 1281-1289.
Polyzos, S. A., & Mantzoros C. S. (2018).  Sixty-six years of Metabolism, Clinical and Experimental: The journey of a journal and opportunities and challenges looking ahead.. Metabolism. 78, A4-A9.
Anastasilakis, A. D., Makras P., Paccou J., Bisbinas I., Polyzos S. A., & Papapoulos S. E. (2023).  Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab.. J Clin Med. 12(18), 
Karras, S. N., Koufakis T., Adamidou L., Polyzos S. A., Karalazou P., Thisiadou K., et al. (2020).  Similar late effects of a 7-week orthodox religious fasting and a time restricted eating pattern on anthropometric and metabolic profiles of overweight adults.. Int J Food Sci Nutr. 1-11.
Polyzos, S. A., Kountouras J., Tsatsoulis A., Zafeiriadou E., Katsiki E., Patsiaoura K., et al. (2013).  Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease.. Hormones (Athens). 12(3), 405-16.
Polyzos, S. A., Kountouras J., Patsiaoura K., Katsiki E., Zafeiriadou E., Zavos C., et al. (2012).  Serum vitamin B12 and folate levels in patients with non-alcoholic fatty liver disease.. Int J Food Sci Nutr. 63(6), 659-66.
Polyzos, S. A., Kountouras J., Romiopoulos I., & Polymerou V. (2013).  Serum visfatin in nonalcoholic fatty liver disease.. Ann Hepatol. 13(1), 150-1.
Gkiomisi, A., Makedou K. G., Anastasilakis A. D., Polyzos S. A., Kourtis A., Gerou S., et al. (2013).  Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum.. Cytokine. 61(1), 127-32.
Polyzos, S. A., Toulis K. A., Goulis D. G., Zavos C., & Kountouras J. (2011).  Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.. Metabolism. 60(3), 313-26.
Polyzos, S. A., Kita M., Efstathiadou Z., Poulakos P., Slavakis A., Sofianou D., et al. (2008).  Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules.. J Cancer Res Clin Oncol. 134(9), 953-60.
Makras, P., Polyzos S. A., Anastasilakis A. D., Terpos E., Kanakis G., Schini M., et al. (2012).  Serum osteoprotegerin, RANKL, and Dkk-1 levels in adults with Langerhans cell histiocytosis.. J Clin Endocrinol Metab. 97(4), E618-21.
Panagiotou, G., Papakonstantinou E., Vagionas A., Polyzos S. A., & Mantzoros C. S. (2019).  Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study.. J Clin Endocrinol Metab. 104(2), 349-358.
Makras, P., Polyzos S. A., Anastasilakis A. D., Terpos E., Papatheodorou A., & Kaltsas G. A. (2012).  Is serum IL-17A a useful systemic biomarker in patients with Langerhans cell histiocytosis?. Mol Ther. 20(1), 6-7.
Polyzos, S. A., Kountouras J., Patsiaoura K., Katsiki E., Zafeiriadou E., Deretzi G., et al. (2012).  Serum homocysteine levels in patients with nonalcoholic fatty liver disease.. Ann Hepatol. 11(1), 68-76.
Polyzos, S. A., Anastasilakis A. D., Efstathiadou Z., Litsas I., Kita M., Panagiotou A., et al. (2010).  Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid.. J Bone Miner Metab. 28(3), 314-9.
Pazaitou-Panayiotou, K., Panagiotou G., Polyzos S. A., & Mantzoros C. S. (2016).  SERUM ADIPONECTIN AND INSULIN-LIKE GROWTH FACTOR 1 IN PREDOMINANTLY FEMALE PATIENTS WITH THYROID CANCER: ASSOCIATION WITH THE HISTOLOGIC CHARACTERISTICS OF THE TUMOR.. Endocr Pract. 22(1), 68-75.
Polyzos, S. A., & Katsiki N. (2022).  Semaglutide, cilofexor, and firsocostat for nonalcoholic steatohepatitis: a dance that may need more than one dancer.. Hormones (Athens).
Polyzos, S. A., Kountouras J., Mavrouli M., Katsinelos P., Doulberis M., Gavana E., et al. (2019).  Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease.. Exp Clin Endocrinol Diabetes.
Polyzos, S. A., Kountouras J., Goulas A., & Duntas L. (2020).  Selenium and selenoprotein P in nonalcoholic fatty liver disease.. Hormones (Athens). 19(1), 61-72.
Avramidis, A., Polyzos S. A., Moralidis E., Arsos G., Efstathiadou Z., Karakatsanis K., et al. (2008).  Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone.. J Bone Miner Metab. 26(6), 635-41.
Polyzos, S. A., & Margioris A. N. (2018).  Sarcopenic obesity.. Hormones (Athens). 17(3), 321-331.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.